Michael Maschan - Concepedia

Author

Michael Maschan

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology ORCID

Also Known As

A. A. Мaschan, Andrej B. Abrosimov, E V Skorobogatova, Iu V Skvortsova, M A MASCHAN, M A Maschan, M Maschan, M. A. Maschan, M. A. Maschan1,, M. A. Мaschan

299

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Institute of Bioorganic Chemistry Pirogov Russian National Research Medical University Skolkovo Institute of Science and Technology Lomonosov Moscow State University

About

Michael Maschan is an author at Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	766
2	Blood Transplantation	6	6	320
3	Allergy	1	1	11
4	Biomedical Engineering	1	1	13
5	Biostatistics	1	1	11

Michael Maschan

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation Tobias Feuchtinger, Kathrin Opherk, Wolfgang Bethge, Blood	2010	429
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study Jean Donadieu, Islam Amine Larabi, M. Tardieu, Journal of Clinical Oncology	2019	210
Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes Dmitry Balashov, Anna Shcherbina, Michael Maschan, Biology of Blood and Marrow Transplantation	2015	140
TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia Michael Maschan, M. A. Ilushina, Elena Kurnikova, Bone Marrow Transplantation Hematological MalignancyTransplantationOncologyCd19 DepletionAcute Myeloid Leukemia	2016	112
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT Bhagirathbhai Dholaria, Bipin N. Savani, Myriam Labopin, Haematologica Cell TherapyTransplantationMarrow TransplantationConsensus RecommendationsStem Cell Transplantation	2019	84
Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita Francesca Fioredda, Simona Iacobelli, Elisabeth T Korthof, British Journal of Haematology TransplantationMarrow TransplantationAutoimmune DiseaseBone Marrow FailureDyskeratosis Congenita	2018	74
Risk Factors for and the Clinical Impact of Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Recipients of TCR-α/β– and CD19-Depleted Grafts Alexandra Laberko, Anna Bogoyavlenskaya, Zhanna Shekhovtsova, Biology of Blood and Marrow Transplantation	2016	66
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients Michael Maschan, Paolo F. Caimi, Jane Reese‐Koc, Nature Communications	2021	66
Low-dose donor memory T-cell infusion after TCR alpha/beta depleted unrelated and haploidentical transplantation: results of a pilot trial Michael Maschan, Sergey Blagov, Zhanna Shekhovtsova, Bone Marrow Transplantation Cell TherapyPilot TrialTransplantationMarrow TransplantationHaploidentical Transplantation	2017	64
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study Elad Jacoby, Sara Ghorashian, Britta Vormoor, Leukemia Hematological MalignancyNeuro-oncologyCell TherapyMedicineCd19 Car T-cells	2022	61

Page 1